On December 1st, 2014, General Manager Wu Hong-tai, advocating to the concept of “Bringing Hope to Human Health”, merged Hua Xing Technology Co., Ltd. and Lihpao life science Co., Ltd. that are developing cell therapy under the Lihpao business group. Open a new chapter in the medical industry with an innovative, practical and caring perspective. LIHPAO LIFE SCIENCE CORP. was established in Tamshi county.
LIHPAO LIFE SCIENCE CORP. business group takes Leopard Gene which is responsible for molecular diagnosis, Leopard Cell which is responsible for cell therapy, and Leopard Medi which is responsible for new drug development as the company’s three business pillars.
Molecular diagnosis business department of Leopard Gene has long been worked within clinical medical institutions and has experiences of laboratory development. In early years, it has established a cancer genetic medicine laboratory in Taipei Veterans General Hospital, and obtained certifications of the CAP of U.S.A and Taiwan Society of Pathology, developed reagent and services for clinical application testing and led the world discovering original tumor resistance mutant gene, and successfully introduced genetic testing to medical order services in 2013. In 2017, it officially stepped out of Taiwan, established a third-party laboratory in Xiamen, China and obtained relevant qualifications, and in accordance with the local NGS testing regulations, it become a local first- and second-class outsourcing unit of hospital testing. Furthermore, in 2019, the Lihpao medical laboratory was established and applied for the ISO15189 laboratory accreditation, and established Yeezen Lihpao laboratory within the Yeezen Hospital in Taiwan. With the development of the genetic testing industry, the LDTS regulations was established, it applied for LDTS accreditation.
Leopard Cell and Leopard Medi based on tumor detection technology, it guides and verifies the selection and research and development of target therapy, proactively develops high-end stem cell storage and immune cell therapy technologies, and develops complete functional healthy product and functional medicine, towards personalized preventive medicine and cell therapy as a blueprint for planning, exert comprehensive effects, benefit the country, and create value chain style medical services.